Susan Abushakra
- Role
- Chief Medical Officer at Alzheon, Inc
- Location
- Boston, MA, US
- LinkedIn followers
- 500 followers
Experience
Chief Medical Officer
Jan 2015 — Present
Alzheon, Inc. is committed to developing innovative medicines for patients suffering from Alzheimer’s disease and other neurological and psychiatric disorders. Our lead clinical candidate, ALZ-801, is a first-in-class, oral inhibitor of amyloid aggregation and neurotoxicity - hallmarks of Alzheimer’s disease. ALZ-801 is an optimized, novel prodrug that builds on the established safety and efficacy profile of the active compound in clinical trials of more than patients. Our mission is to apply our discovery platform and development experience to unlock new classes of therapeutics that make a difference in patients’ lives by directly addressing the underlying pathology of devastating neurodegenerative disorders.
Skills
- Neurology
- Clinical Development
- Pharmaceutical Industry
- Clinical Trials
- Life Sciences
- Regulatory Affairs
- Biotechnology
- Clinical Research
- Oncology
- Drug Development
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.